Stock Analysis: Elekta

Elekta (EKTAF) was founded by Lars Leksell and Laurent Leksell in 1972 and is headquartered in Stockholm, Sweden.

Elekta AB as a medical technology company, provides clinical solutions for the treatment of cancers and brain disorders internationally.

Three key data points gauge EKTAF (or any dividend paying entity):

(1) Price 

(2) Dividends

(3) Returns

Those three keys also indicate if any company has made, is making, and will make money.

EKTAF Price

Elekta’s single share price rose $0.10 (or 1.6%) from $6.00 to $6.10 this past year, per Firday’s morning market report.

No analysts cover the stock. However, a review of he past twenty years of Elekta’s prices shows an average annual increase of $0.10

EKTAF Dividends

Elekta has declared and paid Annual dividends since September 2005, switching to semi-annual frequency in 2013.

The March 2026 SA dividend of $0.14 supports a $0.28 annual dividend estimate for the coming year.

EKTAF Returns

Putting it all together, a hypothetical annual gross gain of $0.38 per share is predicted by adding the $0.28 forward-looking dividend the average EKTAF $0.10 annual price-gain over the past twenty years.

A little over $1000 invested at Friday’s $6.10 share price would buy 164 shares which multiply the $0.38 estimated gross gain to an estimated $62.30 upside for the coming year.

71% of that $62.30 upside gain could come from the $44.30 annual dividend payout from your $1,000 investment.

And the $44.30 dividend from $1k invested is over 7 times more than EKTAF’s $6.10 single share price.

(A dividend dogcatcher rule is to only buy initial shares of a stock that pay an annual dividend from $1000 invested that is greater than the cost of a single share.) 

EKTAF’s $44.30 dividend from $1,000 invested is 7.26 times Friday’s $6.10 single share price. 

The exact track of EKTAF’s  future share price and dividend will entirely be determined by market action and company finances.  

Remember the best way to track stock performance and dividend payments is through direct ownership of company shares.